Germany's Curevac Says Swiss Novartis To Help With Covid Vaccine Production
Muhammad Irfan Published March 04, 2021 | 07:50 PM
Berlin, March 4 (UrduPoint / Pakistan Point News - 4th Mar, 2021 ) :German group Curevac said Thursday it has signed a deal with Novartis for the Swiss pharmaceutical giant to help in its production of the Covid-19 vaccine it is developing.
The Swiss giant will make up to 50 million doses of Curevac's vaccine by the end of 2021 and up to 200 million doses in 2022, said the German company.
CureVac began the final Phase III trials of its vaccine candidate in mid-December, involving more then 35,000 volunteers in Europe and Latin America.
Recent Stories
President Raisi leaves for Iran from Karachi
1 hour ago
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 24 April 2024
2 hours ago
Today Gold Rate in Pakistan 24 April 2024
3 hours ago
Punjab CM inaugurates Pakistan’s first Virtual Women Police Station
13 hours ago
Dutch model Donny Roelvink embraces Islam
13 hours ago
Experts raise concerns over introduction of 10-stick packs
17 hours ago
Iranian president arrives in Karachi
18 hours ago
Law Minister expresses Govt's resolve to address issue of missing persons
18 hours ago
Rizwan’s batting order may be changed: Sources
20 hours ago
Nawaz Sharif to visit Guangzhou exhibition in China
21 hours ago
FM Dar not traveling to China: Foreign Office
22 hours ago
PM takes notice of deliberate delay in tax cases
23 hours ago